Differences Remain in Treatment, Outcomes for Myocardial Infarction – Consumer Health News

WEDNESDAY, July 6, 2022 (HealthDay News) — Despite overall improvements in treatment and outcomes for ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI), differences in treatment and outcomes persist, according to a study published online 21 June in the Annals of Emergency Medicine

Juan Carlos C. Montoy, MD, Ph.D., of the University of California, San Francisco, and colleagues assessed gender and race differences in the treatment of and outcomes for STEMI and NSTEMI. The analysis included 159,068 STEMI and 294,068 NSTEMI presentations in California from 2005 to 2015.

The researchers found that the percentage of patients undergoing timely angiography increased for STEMI (50 percent for men and 35.7 percent for women in 2005 versus 76.7 and 66.8 percent in 2015 respectively) and NSTEMI (45 percent for men and 33.1 percent for women in 2005 versus 56.3 and 45.9 percent in 2015 respectively). At baseline, men had a 1.1 percentage point benefit for one-year STEMI survival, but during the study, survival for women compared to men increased by 0.3 percentage points per year. Timely STEMI angiography increased for all races during the study period, but the differences persisted (46 percent for white patients versus 31.2 percent for black patients in 2005; 75.2 percent for white patients versus 69.2 percent for black patients in 2015).

“Despite these advances, the sex-specific treatment and outcome gaps were large and minimally decreased over this period,” the authors write. “Differences in treatment and outcomes by race and ethnicity varied somewhat and were especially notable because of a significant and increasing gap in the care of black patients with NSTEMI.”

Summary/Full Text

Leave a Comment